Immunic, Inc. Financing Cash Flow
Immunic, Inc. (IMUX) reported Financing Cash Flow of $188.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-11
- Immunic, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $118.00K, a 99.82% decline year-over-year.
- Immunic, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $188.64M.
- Immunic, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $59.00K, a 23.38% decline year-over-year.
- Immunic, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- Immunic, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $65.58M, a 12.03% decline from fiscal 2024.
- Immunic, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $74.54M, a 7115.97% increase from fiscal 2023.
- Immunic, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $1.03M, a 98.92% decline from fiscal 2022.
- Immunic, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $95.76M, a 123.52% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $188.76M 10-Q · filed 2026-08-11 | $188.82M derived: sum of 3 quarters · filed 2026-08-11 | $188.82M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $188.64M 10-Q · filed 2026-05-13 | $188.70M derived: sum of 2 quarters · filed 2026-05-13 | $188.70M derived: sum of 3 quarters · filed 2026-05-13 | $254.22M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $59.00K derived: sum of 2 quarters · filed 2026-02-26 | $65.58M derived: sum of 3 quarters · filed 2026-08-11 | $65.58M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $65.52M derived: sum of 2 quarters · filed 2026-08-11 | $65.52M 10-Q · filed 2025-11-13 | $65.59M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $65.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $65.52M 10-Q · filed 2026-08-11 | $65.59M derived: sum of 3 quarters · filed 2026-08-11 | $65.59M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $77.00K derived: sum of 2 quarters · filed 2026-05-13 | $77.00K derived: sum of 3 quarters · filed 2026-05-13 | $77.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $77.00K derived: sum of 2 quarters · filed 2026-02-26 | $77.00K derived: sum of 3 quarters · filed 2026-02-26 | $74.54M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $74.46M 10-Q · filed 2025-11-13 | $75.07M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $74.46M 10-Q · filed 2025-08-07 | $75.07M derived: sum of 3 quarters · filed 2025-08-07 | $75.35M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $74.46M 10-Q · filed 2025-05-15 | $75.07M derived: sum of 2 quarters · filed 2025-05-15 | $75.35M derived: sum of 3 quarters · filed 2025-05-15 | $75.45M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $886.00K derived: sum of 2 quarters · filed 2025-03-31 | $982.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.03M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $378.00K derived: sum of 2 quarters · filed 2024-11-07 | $429.00K 10-Q · filed 2024-11-07 | $56.47M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $147.00K 10-Q · filed 2024-08-08 | $56.19M derived: sum of 3 quarters · filed 2024-08-08 | $56.19M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $51.00K 10-Q · filed 2024-05-08 | $56.09M derived: sum of 2 quarters · filed 2024-05-08 | $56.09M derived: sum of 3 quarters · filed 2024-05-08 | $66.17M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $56.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $56.04M derived: sum of 2 quarters · filed 2024-02-22 | $66.12M derived: sum of 3 quarters · filed 2024-02-22 | $95.76M 10-K · filed 2024-02-22 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $10.08M derived: sum of 2 quarters · filed 2023-11-14 | $39.72M 10-Q · filed 2023-11-14 | $40.54M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $10.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $39.72M 10-Q · filed 2023-08-03 | $40.54M derived: sum of 3 quarters · filed 2023-08-03 | $82.56M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | $29.64M 10-Q · filed 2023-05-11 | $30.46M derived: sum of 2 quarters · filed 2023-05-11 | $72.48M derived: sum of 3 quarters · filed 2023-05-11 | $72.48M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $821.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $42.84M derived: sum of 2 quarters · filed 2023-02-23 | $42.84M derived: sum of 3 quarters · filed 2023-02-23 | $42.84M 10-K · filed 2023-02-23 | |||
| 2021-09-30 | $42.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $42.02M derived: sum of 2 quarters · filed 2022-11-03 | $42.02M 10-Q · filed 2022-11-03 | $50.13M derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $8.11M derived: sum of 3 quarters · filed 2022-08-04 | $104.65M derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $8.11M derived: sum of 2 quarters · filed 2022-05-10 | $104.65M derived: sum of 3 quarters · filed 2022-05-10 | $143.86M derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $8.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $104.65M derived: sum of 2 quarters · filed 2022-02-24 | $143.86M derived: sum of 3 quarters · filed 2022-02-24 | $144.43M 10-K · filed 2022-02-24 | |||
| 2020-09-30 | $96.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $135.75M derived: sum of 2 quarters · filed 2021-11-04 | $136.32M 10-Q · filed 2021-11-04 | $141.03M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | $39.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $39.78M 10-Q · filed 2021-08-06 | $44.49M derived: sum of 3 quarters · filed 2021-08-06 | $44.71M derived: sum of 4 quarters · filed 2021-08-06 | |||
| 2020-03-31 | $568.00K 10-Q · filed 2021-05-06 | $5.28M derived: sum of 2 quarters · filed 2021-05-06 | $5.50M derived: sum of 3 quarters · filed 2021-05-06 | $14.93M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $4.93M derived: sum of 2 quarters · filed 2021-02-26 | $14.36M derived: sum of 3 quarters · filed 2021-02-26 | $34.90M 10-K · filed 2021-02-26 | |||
| 2019-09-30 | $223.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $9.66M derived: sum of 2 quarters · filed 2020-11-06 | $30.19M 10-Q · filed 2020-11-06 | $36.88M derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $9.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $29.96M 10-Q · filed 2020-08-03 | $36.66M derived: sum of 3 quarters · filed 2020-08-03 | ||||
| 2019-03-31 | $20.53M 10-Q · filed 2020-05-08 | $0.00 10-Q · filed 2019-04-10 | $27.22M derived: sum of 2 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $6.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $19.26M 10-K · filed 2020-03-16 | $4.00K 10-K · filed 2019-03-04 | ||||
| 2018-09-30 | $12.56M 10-Q · filed 2019-11-07 | $4.00K 10-Q · filed 2018-11-08 | |||||
| 2018-03-31 | -$30.00K 10-Q · filed 2019-04-10 | $510.00K derived: sum of 2 quarters · filed 2019-04-10 | |||||
| 2017-12-31 | $540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $37.98M 10-K · filed 2019-03-04 | |||||
| 2017-09-30 | $37.44M 10-Q · filed 2018-11-08 | ||||||
| 2016-12-31 | $12.37M 10-K · filed 2019-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |